Trifork Group (TRIFOR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Q4 2024 delivered record or all-time high revenue, with sequential improvement in growth and margins, and a 1.8%-1.9% year-over-year increase.
The company maintained a strong customer base, retaining 18 of the top 20 customers since IPO, and saw reduced customer concentration.
Strategic focus shifted to product-led business, expanding product/platform sales, cross-selling, and partnerships, with cost savings and margin improvement initiatives underway.
U.S. operations delivered strong growth in Q4, with 69.9% YoY revenue increase, making it a key driver for group growth.
Acquisitions, divestments, and a dividend payout shaped group structure and capital allocation.
Financial highlights
Q4 2024 revenue was EUR 56.0m (+1.8% YoY); full-year 2024 revenue ranged from EUR 205.9m to EUR 207.9m, with a slight YoY decline or modest growth depending on source.
Adjusted EBITDA margin for Q4 was 16.1%; full-year margin was 13.1%, down from 16.9% in 2023.
Net income for 2024 was EUR 17.9m, up from EUR 17.4m in 2023, supported by Labs segment contributions.
Net debt at year-end was EUR 45.9m, with leverage ratio at 1.9x NIBD/Adj. EBITDA; significant net debt reduction occurred in January 2025.
Free cash flow for 2024 was EUR 11.4m, down from EUR 18.1m in 2023.
Outlook and guidance
2025 revenue guidance is EUR 215–225m (4.4–9.3% total growth, 2.9–7.8% organic), with mid-term targets of 10–15% annual growth and 16–20% EBITDA margin.
EBITDA and EBIT margin targets remain unchanged; leverage target of 1.5x continues.
Cost-saving program aims for EUR 10 million annualized savings, with full impact expected by Q3/Q4 2025.
Guidance for 2025 is considered conservative and trustworthy, reflecting lessons from 2024.
Latest events from Trifork Group
- Q1 2025 delivered 14.1% revenue growth, margin gains, and strong Run segment expansion.TRIFOR
Q1 20258 Jul 2026 - Record 2025 revenue, margin gains, and product-led growth set strong outlook for 2026.TRIFOR
Q4 20258 Jul 2026 - Revenue and margins fell in 2024, triggering cost cuts; US and public sector drive growth.TRIFOR
Q3 20248 Jul 2026 - Revenue and margins fell, but public sector wins and Labs gains support future optimism.TRIFOR
Q2 20248 Jul 2026 - Q1 2026 delivered 8% organic growth, 27% EBITDA growth, and improved margins and guidance.TRIFOR
Q1 20265 May 2026 - Q1 2026 saw 27% adjusted EBITDA growth and margin expansion, with 2026 guidance reaffirmed.TRIFOR
Q1 20265 May 2026 - Revenue up 7.3% to EUR 220.9M, strong product growth, margin recovery, and robust outlook.TRIFOR
Q4 202527 Feb 2026 - Product-driven growth, innovation in AI and digital health, and strong 2025 financial targets.TRIFOR
Danske Bank Winter Seminar presentation19 Jan 2026 - Q2 2025 revenue up 5.1%, with product focus and digital health wins fueling future growth.TRIFOR
Investor presentation16 Jan 2026